Skip to content

Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients

Exercise and Myopathies. Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients: Functional, Tissue and Quality of Life Benefits.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01116570
Acronym
FSHD1
Enrollment
15
Registered
2010-05-05
Start date
2010-10-31
Completion date
2015-01-31
Last updated
2015-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscular Dystrophy, Facioscapulohumeral

Keywords

Muscular Dystrophy, Facioscapulohumeral, Physical training, Exercise

Brief summary

It is now accepted that physical activity is not deleterious in myopathies, including muscular dystrophies. In patients suffering from facioscapulohumeral dystrophy (FSHD), aerobic training has been reported to be associated to physiological and functional positive effects without alteration in quality of life. The review papers from Van der Kooi et al. (2005), Cup et al. (2007) and Féasson et al. (2010) suggest that the combination of endurance and strength training is even more relevant. Only a few controlled and randomized studies have been conducted on this topic. The impact of such training programs on the skeletal muscle regenerative capacities has not been yet addressed. Moreover, due to the fact that training programs are mainly performed on short-term supervised periods, there is a lack of knowledge regarding long-term effects, patient's autonomy and whether or not regular exercise practice can be maintained in patient's daily life. Also, only a few experiments have reported an integrative view of the potential benefits of such programs on functional, biological and quality of life.

Detailed description

Our research project aims at establishing a program of physical training that will fulfill the two following conditions: (i) being compatible with the daily professional, social and family activity of the patients so it can be integrated in their life habits and (ii) being intensive enough to induce functional benefits. This experimental work will be based on multi-factorial evaluations, i.e. biological, physiological, functional, and quality of life questionnaires. This work will be based on a collaboration between the Universities of Saint Etienne (L. Féasson), Grenoble (B Wuyam) and Örebro (F Kadi) within the Rhône-Alpes Reference Centre for Rare Neuromuscular Diseases (JC Antoine). It is accepted that exercise therapy can be recommended for patients with myopathies but long-term training load still has to be determined for each pathology. In the specific context of facioscapulohumeral dystrophy, we aim at associating the scientific evaluation of physical activity benefits and a therapeutic education of patients in order to contribute to recommendations for physicians and physiotherapists. The purpose of this study is to combine an integrated approach with a better understanding of biological process implicated in this physiological treatment strategy.

Interventions

OTHERPhysical training

Physical training during 24 weeks

OTHERControl

No intervention

Sponsors

Association Française contre les Myopathies (AFM), Paris
CollaboratorOTHER
Örebro University, Sweden
CollaboratorOTHER
Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* facioscapulohumeral dystrophy * Being capable of supporting an exercise on ergocycle * Social Security regimen affiliated * Consent form signed

Exclusion criteria

* Severe cardiac or respiratory insufficiency * Cardiac pacemaker * Morbid obesity (BMI upper to 35) * Anti platelet therapy

Design outcomes

Primary

MeasureTime frameDescription
maximal oxygen uptake (VO2max)Week 24VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle

Secondary

MeasureTime frameDescription
Questionnaire of quality of lifeDay 0, Week 6, Week 12, Week 18 and Week 24short form 36 health survey questionnaire SF36
BiopsyDay 0 and Week 24biopsy of the vastus lateralis muscle
maximal oxygen uptake (VO2max)Week 6, Week 12 and Week 18VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle
Questionnaire of subjective fatigueDay 0, Week 6, Week 12, Week 18 and Week 24Fatigue severity scale (FSS)
nuclear magnetic resonance imagingInclusionIn Paris centre, a total body NMR imaging will be done with standard T2- and T1-weighted images.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026